These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21701882)

  • 1. Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources.
    Martins MA; Carlos PP; Ribeiro DD; Nobre VA; César CC; Rocha MO; Ribeiro AL
    Eur J Clin Pharmacol; 2011 Dec; 67(12):1301-8. PubMed ID: 21701882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection.
    Martins MA; Ribeiro DD; Nobre VA; Pereira FR; César CC; Rocha MO; Ribeiro AL
    Eur J Clin Pharmacol; 2013 Apr; 69(4):919-28. PubMed ID: 23052411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of severity ratings provided in four drug interaction compendia.
    Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants.
    Acton EK; Willis AW; Gelfand MA; Kasner SE
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1534-1538. PubMed ID: 31517414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs.
    Hines LE; Ceron-Cabrera D; Romero K; Anthony M; Woosley RL; Armstrong EP; Malone DC
    Clin Ther; 2011 Jan; 33(1):36-45. PubMed ID: 21397772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.
    Chao SD; Maibach HI
    Am J Clin Dermatol; 2005; 6(2):105-11. PubMed ID: 15799682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of 5 databases for the identification of warfarin-medication interactions.
    Kornblith A; Heard K
    Clin Appl Thromb Hemost; 2011; 17(6):E95-7. PubMed ID: 21078612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Major Bleeding Among Working-Age Adults with Atrial Fibrillation: Evaluating the Effects of Potential Drug-drug Interactions and Switching from Warfarin to Non-vitamin K Oral Anticoagulants.
    Feng X; Sambamoorthi U; Innes K; Castelli G; LeMasters T; Xiong L; Williams MU; Tan X
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):591-600. PubMed ID: 30315487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the consistency among three drug compendia in listing and ranking of drug-drug interactions.
    Nikolić BS; Ilić MS
    Bosn J Basic Med Sci; 2013 Nov; 13(4):253-8. PubMed ID: 24289762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.
    Olvey EL; Clauschee S; Malone DC
    Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brand name versus generic warfarin: a systematic review of the literature.
    Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
    Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hemorrhage and treatment costs associated with warfarin drug interactions in patients with atrial fibrillation.
    Suh DC; Nelson WW; Choi JC; Choi I
    Clin Ther; 2012 Jul; 34(7):1569-82. PubMed ID: 22717419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study.
    Launiainen T; Sajantila A; Rasanen I; Vuori E; Ojanperä I
    Eur J Clin Pharmacol; 2010 Jan; 66(1):97-103. PubMed ID: 19779704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to improve anticoagulation with warfarin.
    Castro TA; Heineck I
    Ther Drug Monit; 2012 Apr; 34(2):209-16. PubMed ID: 22406649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
    Martinez BK; Baker WL; Sood NA; Bunz TJ; Meinecke AK; Eriksson D; Coleman CI
    Pharmacotherapy; 2019 Feb; 39(2):196-203. PubMed ID: 30597611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin potentiation: a review of the "FAB-4" significant drug interactions.
    Thi L; Shaw D; Bird J
    Consult Pharm; 2009 Mar; 24(3):227-30. PubMed ID: 19555137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of drug-drug interaction in atrial fibrillation patients based on a large claims data.
    Momo K; Kobayashi H; Sugiura Y; Yasu T; Koinuma M; Kuroda SI
    PLoS One; 2019; 14(12):e0225297. PubMed ID: 31815956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.